Aileron approves $204K bonus for President/COO Brian Windsor for FY 2023

Rein Therapeutics, Inc.

Board approved a $204,375 performance-based cash bonus for Brian Windsor (President and COO) for FY 2023.
The bonus updates Windsor's 2023 Summary Compensation Table; total compensation becomes $289,642.
No other named executive officers received a performance-based cash bonus for FY 2023.

item 5.02

Rein Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-032871

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.